Abstract
Phenotyping is commonly used for detection of extended-spectrum beta-lactamase (ESBL) production in gram-negative isolates. ESBLs are mainly coded for by four important genes, namely bla (TEM), bla (SHV), bla (CTX-M), and bla (OXA). Our aim in this study is to assess use of a multiplex PCR as a rapid method to identify four common genes responsible for ESBL production in different gram-negative isolates. All 793 clinical isolates are subjected to both screen and confirmatory testing for ESBL production using double disc synergy testing (DDST). Two hundred isolates with the ESBL phenotype are subjected to multiplex PCR for detection of the four genes bla (TEM, SHV, CTX-M, and OXA). The isolates were obtained from various clinical specimens: 68 (34 %) were isolated from urine cultures, 43 (21.5 %) from sputum, 26 (13 %) from wounds, 34 (17 %) from blood culture, 20 (10 %) from stool of healthy carrier and nine (4.5 %) from bronchoalveolar lavages. In this study, 83 isolates (41.5 %) were from outpatients (urine and stool specimens only), and the remaining 117 isolates (58.5) were from inpatients. By PCR technique, 181 isolates were found to be ESBL producers. blaTEM was the commonest genotype (39.2 %), followed by blaSHV (32.5 %) and blaCTX-M (30.9 %), either alone or in combination. Acinetobacter baumannii isolate had none of the ESBL genes. Eighteen (9.9 %) out of 181 isolates carried more than one type of beta-lactamase genes. Our study demonstrated rapid detection of bla (TEM, SHV, CTX-M, and OXA) in isolates belonging to Enterobacteriaceae and other nonfermenting clinical isolates using multiplex PCR. This genotypic method provided a rapid and efficient differentiation of ESBLs in the laboratory.
Similar content being viewed by others
References
Akcam FZ, Gönen I, Kaya O, Yaylı G (2004) The determination of susceptibility of beta-lactam antibiotics and extended spectrum beta-lactamase production in Enterobactericeae which responsible from nosocomial infections. Med J Sdu 11:6–9
Baron EJ, Finegold SM (1990) Bailey and Scott's diagnostic microbiology, 8th edn. CV Mosby Company, St. Louis
Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1–14
Borg MA, Scicluna E, De Kraker M et al (2006) Antibiotic resistance in the southeastern Mediterranean preliminary results from the ARMed project. Euro Surveill 11(7):164–167
Bouchillon SK, Johnson BM, Hoban DJ et al (2004) Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002. Int J Antimicrob Agents 24(2):119–124
Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, Bryce E et al (2004) Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 48:3758–3764
Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14:933–951
Bülüç M, Gürol Y, Bal Ç (2003) Rates of extended spectrum beta lactamases: 2000–2002. Turk Microbiol Soc 33:31–34
Bush K (2001) New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32:1085–1089
Canton R, Novais A, Valverde A et al (2008) Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14:144–153
Chanawong A, M'Zali FH, Heritage J, Lulitanond A, Hawkey PM (2001) SHV-12, SHV-5, SHV-2a, and VEB-1 extended-spectrum β-lactamases in gram-negative bacteria isolated in a university hospital in Thailand. J Antimicrob Chemother 48:839–852
Delialioğlu N, Öcal ND, Emekdaş G (2005) Rates of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella species isolated from various clinical specimens. Ankem 19:84–87
Eiman MA, Rasha HE (2011) High rates of intestinal colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy individuals. J Investig Med 59:1284–1286
Essack SY, Hall LM, Pillay DJ, McFadyen ML, Livermore DM (2001) Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa, Antimicrob Agents Chemother 45(1):88–95
Fang H, Lundberg C, Olsson-Liljequist B, Hedin G, Lindback E, Rosenberg A, Struwe J (2004) Molecular epidemiological analysis of Escherichia coli isolates producing extended-spectrum beta-lactamases for identification of nosocomial outbreaks in Stockholm, Sweden. J Clin Microbiol 42:5917–5920
Gupta V (2007) An update on newer beta-lactamases. Indian J Med Res 126:417–427
Jarlier V, Nicolas MH, Fournier G, Philippon A (1988) Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867–877
Johnson A, Woodford N (1998) Plasmid analysis. In: Johnson A, Woodford P (eds) Molecular bacteriology protocols and clinical application. Human Press, London, pp 24–28
Kariuki S, Corkill JE, Revathi G, Musoke R, Hart CA (2001) Molecular characterization of a novel plasmiden coded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Antimicrob Agents Chemother 45(7):2141–2143
Khalaf NG, Eletreby MM, Hanson ND (2009) Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect Dis 9:84
Kimura S, Ishii Y, Tateda K, Yamaguchi K (2007) Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167. Int J Antimicrob
Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ et al (2007) Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumonia in a children's hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 60:629–637
Moland ES, Kim SY, Hong SG, Thompson KS (2008) Newer beta lactamases: clinical and laboratory implications, part I and II. Clin Microbiol Newsl 30(10):71–85
Monstein HJ, Stholm-Balkhedm AO, Nilsson MV, Nilsson M, Dornbusch K, Nilsson LE (2007) Multiplex PCR amplification assay for the detection of blaSHV, blaTEM, and blaCTX-M genes in Enterobacteriaceae. APMIS 115:1400–1408
Moore KL, Kainer MA, Badrawi N, Afifi S, Wasfy M, Bashir M et al (2005) Neonatal sepsis in Egypt associated with bacterial contamination of glucose-containing intravenous fluids. Pediatr Infect Dis J 24(7):590–594
NCCLS (2002) Performance standards for antimicrobial susceptibility testing. 12th informational supplement. NCCLS document M100-S12. National Committee for Clinical Laboratory Standards, Wayne
Ouellette M, Bissonnette L, Roy PH (1987) Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 beta-lactamase gene. Proc Natl Acad Sci USA 84:7378–7382
Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB et al (2004a) Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamases-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 48:3720–3728
Pai H, Hong JY, Byeon JH, Kim YK, Lee HJ (2004b) High prevalence of extended-spectrum β-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. Antimicrob Agents Chemother 48:3159–3161
Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, Bonomo RA (2003) The International Klebsiella Study Group extended-spectrum beta lactamases in Klebsiella pneumonia bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob Agents Chemother 47:3554–3560
Pitout JD, Reisbig MD, Venter EC, Church DL, Hanson ND (2003) Modification of the double-disk test for detection of Enterobacteriaceae producing extended-spectrum and AmpC β-lactamases. J Clin Microbiol 41(8):3933–3935
Robberts FJ, Kohner PC, Patel R (2009) Unreliable extended spectrum beta-lactamase detection in the presence of plasmid-mediated AmpC in Escherichia coli clinical isolates. J Clin Microbiol 47:358–361
Shah AA, Hasan F, Ahmed S, Hameed A (2004) Characteristics, epidemiology and clinical importance of emerging strains of gram-negative bacilli producing extended-spectrum beta-lactamases. Res Microbiol 155:409–421
Shahid M, Singhal M, Malik A, Shukla I, Khan HM (2006) ESBL phenotypes and prevalent genotype of CTX-M type beta lactamases in clinical isolates of E. coli in a North Indian tertiary care hospital. 46:70
Sinha M, Srinivasa H, Macaden R (2007) Antibiotic resistance profile and extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 12(6):63–67
Timko J (2004) Changes of antimicrobial resistance and extended-spectrum beta-lactamase production in Klebsiella spp. strains. J Infect Chemother 10:212–215, Agents. 29: 326-331
Turner PJ (2005) Extended spectrum beta-lactamases. Clin Infect Dis 41:273–275
Velasco C, Romeroa L, Martinez MR, Rodríguez-Baño J, Pascual A (2007) Analysis of plasmids encoding extended-spectrum beta lactamases (ESBLs) from Escherichia coli isolated from nonhospitalised patients in Sevile. Int J Antimicrob Agents 29:89–92
Author information
Authors and Affiliations
Corresponding author
Additional information
The study was done in Cairo University, Egypt.
Rights and permissions
About this article
Cite this article
El sherif, R.H., Maamoun, H.A.H. Molecular characteristics of extended-spectrum beta-lactamases among gram-negative isolates collected in Cairo University Hospital. Comp Clin Pathol 22, 733–739 (2013). https://doi.org/10.1007/s00580-012-1475-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00580-012-1475-9